FCFang Chen

Fang Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fang Chen has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Jihong Zhang

    Hematology Laboratory, Shengjing Hospital of China Medical University, Shenyang, China

    4 shared publications
  • Shuang Fu

    Department of Hematology Laboratory, Shengjing Hospital of China Medical University, Shenyang, PR China

    3 shared publications
  • Shuang Fu

    Hematology Laboratory, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China

    2 shared publications
  • Yu Fu

    Department of Hematology Laboratory, Shengjing Hospital of China Medical University, Shenyang, PR China

    2 shared publications
  • Bin Wu

    Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, PR China

    1 shared publication
  • Binghui Shen

    Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA, USA

    1 shared publication

Latest Publications

  • Open Access

    New selective and allosteric FLT3 inhibitors show efficacy against resistant acute myeloid leukemia cells

    by Shuai-Shuai Ge, Qiao-Cheng Qiu, Jingsheng Hua, Jun Wang, Minfeng Yang, Jiahui Du, Yuan-Hong Huang, Chao-Ling Wan, Ling-Ling Liu, Hai-Ping Dai, et al.


  • MAPK3 modulates enhancer–promoter interactions of SKAP2 in acute myeloid leukemia

    by Yanping Hu, Fang Chen, Tingjie Wang, Bo Wang, Zhizhong Wang, Jiawen Zheng, Yifen Shen, Yihang Shen, Jie Ma, Yongjun Guo

    The regulation of gene expression through chromatin architecture plays a critical role in acute myeloid leukemia (AML). In this study, the influence of MAPK3 on CTCF-mediated chromatin interactions in AML was examined, focusing on gene regulation and chromatin architecture. Immunoprecipitation coupled with mass spectrometry (IP-MS) was conducted to identify CTCF-binding proteins in AML cell lines. Chromatin immunoprecipitation sequencing (ChIP-seq) was used to assess the impact of MAPK3 modulation on CTCF DNA binding, following treatment with an MAPK3 activator or inhibitor. Additionally, chromatin interactions were evaluated using 3C-qPCR, and specific enhancer sites at the SKAP2 locus were deleted using CRISPR-Cas9. Results demonstrated that IP-MS identified MAPK3 as a key CTCF-binding protein, indicating its potential role in AML chromatin regulation. MAPK3 significantly influences CTCF binding at distal intergenic regions upstream of SKAP2, as confirmed by ChIP-seq. Chromatin interaction analyses revealed that CTCF-regulated enhancer–promoter interactions at SKAP2 are modulated by MAPK3 activity. Furthermore, deletion of enhancer regions E4 and E6 led to decreased SKAP2 expression. These findings highlight the critical role of MAPK3 in regulating CTCF-mediated chromatin interactions and suggest that targeting MAPK3-regulated chromatin remodeling could be a novel therapeutic strategy for AML.

  • MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation

    by Jianing Liu, Jianan Xu, Rongcan Sun, Xiaohui Wang, Fang Chen, Yu Fu, Henan Zhang, Bin Wu, Ying Yang, Jihong Zhang, et al.

    Acute myeloid leukemia (AML) is a heterogeneous clonal disease. Membrane-associated ring-CH type finger 1 (MARCH1), a membrane-anchored E3 ubiquitin ligase, is highly expressed in AML. However, its role in AML remains unclear. Our study showed that MARCH1 expression was strongly associated with FAB classifications and the survival of patients with AML. Gain-of-function and loss-of-function experiments showed that MARCH1 promoted the proliferation of AML cells and inhibited apoptosis and differentiation. In vivo, MARCH1 knockdown inhibited the infiltration of AML cells, resulting in prolonged survival of AML mice. In order to illustrate what cause the high expression of MARCH1, we analyzed the promoter region of MARCH1 and found that POU2F2, a transcription factor with high levels in AML, positively regulated the transcription of MARCH1. Finally, we demonstrated that MARCH1 interacted with MYCT1, a candidate tumor suppressor, and accelerated its ubiquitination and degradation. Remarkably, MYCT1 knockdown abolished the inhibitory effects of MARCH1 knockdown on AML cell growth. Our findings indicate that MARCH1, whose transcription is positively modulated by POU2F2, facilitates the malignant behaviors of AML cells through interacting with MYCT1 and accelerating its ubiquitination and degradation. The results implied that targeting MARCH1 might be a promising therapeutic strategy for AML.


  • Functional Landscape of hnRNPA3 in Disease Pathogenesis

    by Fang Chen, Genghan Li, Shuang Fu, Jihong Zhang

    The heterogeneous nuclear ribonucleic acid protein family participates in various intracellular reactions, such as RNA splicing, transport, DNA repair, cellular signal transduction, and gene expression regulation, and is involved in various disease processes. As a late‐discovered member, heterogeneous nuclear ribonucleoprotein A3 has received increasing attention, but its main physiological functions and exact mechanisms involved in disease processes have not yet reached a consensus. In this review, we summarize the function of heterogeneous nuclear ribonucleoprotein A3 and the literature on its role in neurodegenerative and metabolic diseases, as well as in various tumors, to explore the applicability of heterogeneous nuclear ribonucleoprotein A3 as a therapeutic target and prognostic indicator.


  • Trends in pretreatment and determination methods for furfurals in foods: Update since 2017

    by Tong-Yi Zhao, Yu Bian, Yu Zhou, Yuan Zhang, Xue-Song Feng, Fang Chen


  • The diagnostic and therapeutic potential of multiple myeloma–associated circular RNAs

    by Yue Zhao, Shaokun Wang, Shuang Fu, Xinxin Wang, Jihong Zhang, Fang Chen


  • Open Access

    Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection

    by Yu Fu, Fang Chen, Lifen Cui, Yue Zhao, Henan Zhang, Shuang Fu, Jihong Zhang

    Clarifying changes in the immune microenvironment caused by vaccination is crucial for the development and application of vaccines. In this study, we analyzed seroconversion of antibodies, 12 key cytokines, and 34 lymphocyte subsets at three time points (D-1, D14, and D42) around vaccination and differences between two inactivated vaccines (Sinopharm and Sinovas) to understand the immune response induced by inactivated vaccines in the real world. The results showed that 62.5% and 75% of the participants achieved neutralizing antibody seroconversion on D14 and D42, respectively. After vaccination, IL-5 and IL-6 increased, and INF-γ decreased. IL6, IL-1B, INF-γ, IL-8, and IL-12p70 showed statistical significance in the comparison of different groups. In terms of lymphocyte subsets, CD3 +, CD56 +, CD3 + CD8 +, CD8 + CD71 +, and CD56 + CD71 + showed upward trend, while CD19 +, CD4 + CD8 +, CD8 + CD45RA +, CD4 + HLA-DR +, CD8 + HLA-DR +, and CD8 + CD38 + showed downward trend. Additionally, we found certain differences between the two vaccines in neutralizing antibodies, cytokines, and lymphocyte subsets. This research is a clinical observation on the immune response after vaccination through detecting various immune indicators, which showed that the inactivated vaccines induced both humoral immunity by producing neutralizing antibodies and cellular immunity. The cellular immunity induced by these two vaccines was a Th2-biased response, and it may also lead to a mild Th1-type response.


  • Open Access

    Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis

    by Fang Chen, Yanping Hu, Xiaohui Wang, Shuang Fu, Zhuogang Liu, Jihong Zhang

    In this study, the immunophenotype was retrospectively analyzed in 131 patients who received initial treatment for plasma cell myeloma (PCM) and the relationships of CD81 and CD117 with the clinicopathologic characteristics and prognosis were further evaluated. The Kaplan and Meier method and Cox regression survival analysis model were used to determine whether CD117 and CD81 were factors affecting the overall survival (OS) and progression‐free survival (PFS) of PCM patients. CD117 and CD81 positivity was demonstrated in 35.88% and 40.46% of the 131 patients, respectively. Kaplan‐Meier analysis showed that CD117 and CD81 were potential predictors of a patient's prognosis. Specifically, CD117(+) patients had longer PFS (P = 0.033) and OS (P = 0.002), while CD81(+) patients had shorter PFS (P = 0.001) and OS (P = 0.002). CD117(+) and CD81(−) patients had the longest PFS [P = 0.0183 compared to the CD117(−)CD81(−)/CD117(+)CD81(+) group;P = 0.0007 compared to the CD117(−)CD81(+) group] and the longest OS [P = 0.0331 compared to the CD117(−)CD81(−)/CD117(+)CD81(+) group;P = 0.0005 compared to the CD117(−)CD81(+) group]. Our results show that CD81 is an independent factor affecting the OS and PFS of PCM patients, and CD117 is an independent factor affecting the OS of PCM patients. CD117‐positive and CD81‐negative patients with PCM have a better prognosis.


  • Influence of patchy saturation on seismic dispersion and attenuation in fractured porous media

    by Jinwei Zhang, Handong Huang, Chunhua Wu, Sheng Zhang, Gang Wu, Fang Chen

    Wave induced fluid flow due to mesoscopic heterogeneity can explain seismic dispersion and attenuation in the seismic frequency band. The mesoscopic heterogeneity mainly contains lithological variations, patchy saturation and mesoscopic fractures. The patchy saturation models which are locally based on Biot theory for porous media have been deeply studied, but the patchy saturation model for fractured porous media is rarely studied. In this paper, we develop a model to describe the poroelastic characteristics in fractured porous media where the background and fractures are filled with different fluids based on two scales of squirt flow. The seismic dispersion and attenuation in fractured porous media occur in two scales, the microscale due to fluid flow between pores and micro-cracks and mesoscale due to fluid flow between background and heterogeneities. We derive the complex stiffness tensor through the solution of stress equivalence and fluid conservation. Two new parameters embodying the fluid effects are introduced into the model compared with the single fluid phase model. The model is consistent with Gassmann-Wood equation at low frequency limit and consistent with the isolated fracture model at high frequency limit. After the frequency dependent stiffness tensor is obtained, the variations of velocities and inverse quality factors with frequency are analyzed through several numerical examples. We investigated three poroelastic cases: medium including pores and micro-cracks, media including pores, micro-cracks and fractures, media including pores and fractures. The frequency dependent characteristics of patchy saturation model are different with those of single fluid model not only in characteristic frequency but also in the magnitude of the attenuation. Finally, we discuss the results obtained and the special case where the fractures are saturated with gas or dry and the background is filled with water. We also compare our results with those of patchy saturation model and double porosity model. The results will contribute to the actual exploration work to a certain extent, such as the fluid identification in fractured reservoirs.


  • Open Access

    Non-invasive fetal sex determination by maternal plasma sequencing and application in X-linked disorder counseling

    by Xiaoyu Pan, Chunlei Zhang, Xuchao Li, Shengpei Chen, Huijuan Ge, Yanyan Zhang, Fang Chen, Hui Jiang, Fuman Jiang, Hongyun Zhang, et al.

    Objective: To develop a fetal sex determination method based on maternal plasma sequencing (MPS), assess its performance and potential use in X-linked disorder counseling. Methods: 900 cases of MPS data from a previous study were reviewed, in which 100 and 800 cases were used as training and validation set, respectively. The percentage of uniquely mapped sequencing reads on Y chromosome was calculated and used to classify male and female cases. Eight pregnant women who are carriers of Duchenne muscular dystrophy (DMD) mutations were recruited, whose plasma were subjected to multiplex sequencing and fetal sex determination analysis. Results: In the training set, a sensitivity of 96% and false positive rate of 0% for male cases detection were reached in our method. The blinded validation results showed 421 in 423 male cases and 374 in 377 female cases were successfully identified, revealing sensitivity and specificity of 99.53% and 99.20% for fetal sex determination, at as early as 12 gestational weeks. Fetal sex for all eight DMD genetic counseling cases were correctly identified, which were confirmed by amniocentesis. Conclusions: Based on MPS, high accuracy of non-invasive fetal sex determination can be achieved. This method can potentially be used for prenatal genetic counseling.